Dissecting, And Demystifying, An NIH Grant Application

“I have been writing grant proposals the way I saw fit all my life, and I never had a problem until recently,” a Harvard Medical School emeritus professor told me some months ago, “but now my colleagues tell me I have to follow the instructions.” I didn’t appreciate the importance of certain details, either—until I began to review grant applications. Although much of the National Institutes of Health application packet is self-explanatory or is explained

Written byLiane Reif-lehrer
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

“I have been writing grant proposals the way I saw fit all my life, and I never had a problem until recently,” a Harvard Medical School emeritus professor told me some months ago, “but now my colleagues tell me I have to follow the instructions.”

I didn’t appreciate the importance of certain details, either—until I began to review grant applications. Although much of the National Institutes of Health application packet is self-explanatory or is explained in the instructions, some insight from a former reviewer may ease the work of filling out your next application. I will use the NIH/PHS-398 form (ROl) as an example.

Although the initial pages in almost any grant application require seemingly straightforward administrative and financial information, you should give serious consideration to how you fill in the blanks.

When you decide on the title of the application, for example, keep in mind that it is one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies